Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (25 quarters reported)
$65.2M in Q2 2013 → $22.4M now. Hover for any quarter.
As reported for the quarter ended September 30, 2020. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Champions Oncology Inc | 100.0% | Unchanged | 2,421,673 | $22.4M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2020 · filed November 16, 2020
No position changes this quarter.
quarter ended June 30, 2020 · filed August 14, 2020
No position changes this quarter.
quarter ended March 31, 2020 · filed May 15, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Nutanix Inc | Exited | −1,719,290 | −$53.7M | — |
| Fastly Inc | Exited | −1,174,951 | −$23.6M | — |
| Champions Oncology Inc | Added | +409,791 | +$3.03M | 100.0% |
| Phunware Inc | Exited | −588,327 | −$700K | — |
quarter ended December 31, 2019 · filed February 14, 2020
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| A Avalara Inc | Exited | −1,327,604 | −$89.3M | — |
| Fastly Inc | Added | +85,623 | +$1.72M | 24.9% |
quarter ended September 30, 2019 · filed November 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| A Avalara Inc | Trimmed | −2,777,492 | −$187M | 51.7% |
| Fastly Inc | New | +1,089,328 | +$26.1M | 15.1% |
quarter ended June 30, 2019 · filed August 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| A Avalara Inc | Trimmed | −1,009,999 | −$72.9M | 82.7% |
quarter ended March 31, 2019 · filed May 14, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| A Avalara Inc | Trimmed | −570,649 | −$31.8M | 75.5% |
| Nutanix Inc | Trimmed | −45,000 | −$1.7M | 17.2% |
| Champions Oncology Inc | Added | +58,333 | +$571K | 5.2% |
quarter ended December 31, 2018 · filed February 13, 2019
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Phunware Inc | New | +588,327 | +$8.39M | 3.1% |
| Nutanix Inc | Trimmed | −42,420 | −$1.76M | 26.8% |
Loading...
